Autolus Therapeutics annual gross margin
2023
2024
2025
Autolus Therapeutics Gross Margin Growth & History (AUTL)
Autolus Therapeutics's gross margin was −27.83% for fiscal 2025.
View full Autolus Therapeutics company overviewAutolus Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −27.83% | −15.31 pp |
| 2024 | 2024-12-31 | −12.52% | −112.52 pp |
| 2023 | 2023-12-31 | 100.00% | — |
Autolus Therapeutics quarterly gross margin
Q1.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 55.20% | +72.03 pp |
| Q1 2026 | 2026-03-31 | 6.29% | +106.15 pp |
| Q4 2025 | 2025-12-31 | −4.29% | +39161.23 pp |
| Q3 2025 | 2025-09-30 | −35.15% | — |
| Q2 2025 | 2025-06-30 | −16.83% | — |
| Q1 2025 | 2025-03-31 | −99.86% | −199.86 pp |
| Q4 2024 | 2024-12-31 | −39,165.52% | — |
| Q1 2024 | 2024-03-31 | 100.00% | — |
Autolus Therapeutics gross margin trends
Between the periods ended 2023-12-31 and 2025-12-31, Autolus Therapeutics's gross margin decreased from 100.00% to −27.83%, a change of −127.83 percentage points. The latest reported quarter, Q2 2026, shows 55.20%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Autolus Therapeutics source filings ↗